(19)
(11) EP 4 337 175 A1

(12)

(43) Date of publication:
20.03.2024 Bulletin 2024/12

(21) Application number: 22728900.6

(22) Date of filing: 13.05.2022
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/41(2006.01)
 A61K 31/216(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2054; A61K 9/2018; A61K 9/2027; A61K 9/2009; A61K 31/41; A61K 31/216
 
C-Sets:
  1. A61K 31/41, A61K 2300/00;
  2. A61K 31/216, A61K 2300/00;
(86) International application number:
PCT/EP2022/063043
(87) International publication number:
WO 2022/238563 (17.11.2022 Gazette 2022/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.05.2021 EP 21173895

(71) Applicant: KRKA, d.d., Novo mesto
8501 Novo mesto (SI)

(72) Inventors:
  • BENKOVIC, Marko
    8501 Novo mesto (SI)
  • KLEMENT, Dejan
    8501 Novo mesto (SI)
  • MEZNAR, Klavdija
    8501 Novo mesto (SI)
  • PODGORSEK, Katja
    8501 Novo mesto (SI)
  • SLANC VOVK, Janika
    8501 Novo mesto (SI)
  • KORASA, Klemen
    8501 Novo mesto (SI)
  • SMRKOLJ, Matej
    8501 Novo mesto (SI)

(74) Representative: Kutzenberger Wolff & Partner 
Waidmarkt 11
50676 Köln
50676 Köln (DE)

   


(54) PHARMACEUTICAL FORMULATION OF VALSARTAN AND SACUBITRIL